FAKTOR OPTIONSSCHEIN - DEXCOM Share Price

DE000GQ7JUY7

Real-time BOERSE MUENCHEN 19:25:11 20/06/2024 BST
1.59 ^EUR	-0.62%

Current month	-31.62%
1 month	-88.18%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

Glucotrack Announces the Appointment of Andy Balo to Board of Directors	01:30pm	CI
Dexcom Expands AID Partnership Into The Netherlands	12:16pm	BU
Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes	11:06am	BU
DexCom : William Blair 44th Annual Growth Stock Conference	06-05	PU

More news

Quotes 5-day view

Date	Price	Change
20/06/24	1.59	-0.62%
19/06/24	1.6	-4.19%
18/06/24	1.67	-6.18%
17/06/24	1.78	+21.09%
14/06/24	1.47	+8.09%

Real-time BOERSE MUENCHEN

Last update June 20, 2024 at 07:25 pm

More quotes

Static data

Product type	Exotische Produkte
Buy / Sell	CALL
Underlying	DEXCOM, INC.
Issuer	Goldman Sachs
WKN	GQ7JUY
ISIN	DE000GQ7JUY7
Date issued	16/10/2023
Strike	106.9 $
Maturity	Unlimited
Parity	5.61 : 1
Emission price	9.03 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	358 €
Lowest since issue	1.24 €
Spread	0.02 €
Spread %	1.27%

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

116.6 USD

Average target price

150.3 USD

Spread / Average Target

+28.89%

Consensus